rs3915129

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001904.4(CTNNB1):​c.-49+2581T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.402 in 152,016 control chromosomes in the GnomAD database, including 12,642 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 12642 hom., cov: 32)

Consequence

CTNNB1
NM_001904.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.456

Publications

27 publications found
Variant links:
Genes affected
CTNNB1 (HGNC:2514): (catenin beta 1) The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
CTNNB1 Gene-Disease associations (from GenCC):
  • exudative vitreoretinopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • severe intellectual disability-progressive spastic diplegia syndrome
    Inheritance: Unknown, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
  • exudative vitreoretinopathy 7
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.451 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001904.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTNNB1
NM_001904.4
MANE Select
c.-49+2581T>G
intron
N/ANP_001895.1P35222
CTNNB1
NM_001098209.2
c.-49+2581T>G
intron
N/ANP_001091679.1P35222
CTNNB1
NM_001098210.2
c.-49+2581T>G
intron
N/ANP_001091680.1P35222

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTNNB1
ENST00000349496.11
TSL:1 MANE Select
c.-49+2581T>G
intron
N/AENSP00000344456.5P35222
CTNNB1
ENST00000396183.7
TSL:1
c.-49+2581T>G
intron
N/AENSP00000379486.3P35222
CTNNB1
ENST00000396185.8
TSL:1
c.-49+2581T>G
intron
N/AENSP00000379488.3P35222

Frequencies

GnomAD3 genomes
AF:
0.402
AC:
61120
AN:
151898
Hom.:
12636
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.334
Gnomad AMI
AF:
0.433
Gnomad AMR
AF:
0.367
Gnomad ASJ
AF:
0.382
Gnomad EAS
AF:
0.247
Gnomad SAS
AF:
0.408
Gnomad FIN
AF:
0.459
Gnomad MID
AF:
0.370
Gnomad NFE
AF:
0.456
Gnomad OTH
AF:
0.398
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.402
AC:
61155
AN:
152016
Hom.:
12642
Cov.:
32
AF XY:
0.398
AC XY:
29609
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.334
AC:
13839
AN:
41470
American (AMR)
AF:
0.367
AC:
5601
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.382
AC:
1322
AN:
3462
East Asian (EAS)
AF:
0.247
AC:
1280
AN:
5174
South Asian (SAS)
AF:
0.407
AC:
1961
AN:
4814
European-Finnish (FIN)
AF:
0.459
AC:
4846
AN:
10550
Middle Eastern (MID)
AF:
0.374
AC:
110
AN:
294
European-Non Finnish (NFE)
AF:
0.456
AC:
30969
AN:
67952
Other (OTH)
AF:
0.395
AC:
834
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1866
3732
5599
7465
9331
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
576
1152
1728
2304
2880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.432
Hom.:
18970
Bravo
AF:
0.393
Asia WGS
AF:
0.367
AC:
1281
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
6.0
DANN
Benign
0.66
PhyloP100
-0.46
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3915129; hg19: chr3-41243742; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.